Nova MD review
A $175/mo semaglutide, $199/mo tirzepatide compounded option carrying its own FDA warning letter (September 2025) for a 'same active ingredient as Wegovy & Ozempic' claim the FDA called misleading.
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Nova MD at a glance
- Semaglutide
- $175/mo
- Tirzepatide
- $199/mo
- Coverage
- Not disclosed — no published state list
- Brand-name
- Compounded only
How we scored Nova MD
Each factor is scored from Nova MD's real pricing, disclosures and oversight, then combined into the 45/100 Editors' Rating by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable, premium, or hides behind a plan commitment.
Limited public detail on who oversees care and how.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- trynovamd.com
Live-checked 2026-08-04. trynovamd.com lists 'Compounded GLP-1' at $175/mo (1-month) or $125/mo (3-month), and 'Compounded GLP-1 + GIP' at $199/mo (1-month) or $169/mo (3-month) — the 1-month, no-commitment rate is headlined here. Process is a '5-minute' online questionnaire reviewed same-day by a licensed physician; no live-video language found. The FDA issued a warning letter to Try Nova (MARCS-CMS 716695, dated September 9, 2025) reviewing trynovamd.com and citing the claim 'Same active ingredient as Wegovy & Ozempic' as false or misleading, causing misbranding under FD&C Act sections 502(a) and 502(bb) — the FDA's concern is that the phrase implies equivalence to the FDA-approved product. Domain in the letter matches this candidate's domain exactly. No follow-up resolution found as of this check.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $175 | 1-month billing, no commitmentSold as 'Compounded GLP-1.' Drops to $125/mo on 3-month prepaid billing — a prepay rate, not the standard price. |
| Compounded tirzepatide | $199 | 1-month billing, no commitmentSold as 'Compounded GLP-1 + GIP.' Drops to $169/mo on 3-month prepaid billing — a prepay rate, not the standard price. |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect Nova MD's public disclosures at last review and change often; confirm the current number on Nova MD's own site.
What we like
- Both molecules available at a mid-range flat price
- Fast, described 5-minute intake reviewed same-day, no live-video requirement found
- No separate membership fee mentioned
- The 3-month prepay tier is disclosed on the same page as the standard rate
The caveats
- Carries its own FDA warning letter for a misleading 'same active ingredient' claim
- No published state list
- No published support-channel details
- Compounded only — no FDA-approved brand-name option
Nova MD for mothers: our verdict
A $175/mo semaglutide, $199/mo tirzepatide compounded option carrying its own FDA warning letter (September 2025) for a 'same active ingredient as Wegovy & Ozempic' claim the FDA called misleading. It runs about $175/month, flat across every dose — a premium to the category, so the extras have to earn it.
We weigh Nova MD the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the parts a generic weight-loss review skips.
What Nova MD actually costs
- Compounded semaglutide — 1-month billing, no commitment: $175/mo
- Compounded tirzepatide — 1-month billing, no commitment: $199/mo
For context, the typical ongoing price across our roster is around $150/month, so Nova MD sits at the premium end.
The medications Nova MD prescribes
Nova MD prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Nova MD fits — and where it doesn't — for mothers
A good fit if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Nova MD is a provider we list only with full disclosure — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Families who read the FDA letter first and still want a straightforward, no-membership compounded option at a mid-range price.
Alternatives to Nova MD
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Nova MD
Head-to-head & alternatives
Nova MD, answered
- Does Nova MD have an FDA warning letter?
- Yes — the FDA sent Try Nova (trynovamd.com) a warning letter dated September 9, 2025, over the claim 'Same active ingredient as Wegovy & Ozempic,' which the FDA said implies equivalence to the FDA-approved product and called misbranding.
- What does Nova MD cost?
- $175/mo for 'Compounded GLP-1' (semaglutide) on 1-month billing, or $199/mo for 'Compounded GLP-1 + GIP' (tirzepatide). Both drop on a 3-month prepay ($125/$169) — a prepay discount, not the standard rate.
Pricing, states and verification reflect Nova MD's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.